Levofloxacin in 5% Dextrose Injection
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Bacteria, mold, yeast or other microorganisms detected in the product. Contamination can occur from water systems, equipment or handling, and can cause infection.
1,002 FDA drug recalls with this cause, newest first.
These recalls involve bacteria, mold, yeast or other microorganisms actually found in the finished product. This overlaps with sterility issues but is tracked separately because it usually points to a specific breakdown - a water system, an unsealed container, a contaminated raw material - rather than a general process failure. It carries a large share of Class I recalls: an organism such as Burkholderia cepacia or Pseudomonas in an eye drop, nasal spray or oral liquid can cause serious infection.
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Lack of Assurance of Sterility; confirmed customer report of a leaking bags and mold found between the outer bag and the overwrap
Microbial Contamination of Non-Sterile Products: Bioburden out of specification results for Morphine Sulfate API.
Microbial contamination of Non-Sterile Product; product contamination with yeast and mold (Paecilomyces saturatus and Aspergillus fumigatus).
Presence of Particulate Matter; contains visible particulate matter identified as mold.
Microbial Contamination of Non-Sterile Products.
Presence of Particulate Matter; white particulate matter identified as mold was found in one bag
Microbial Contamination of Non-Sterile Products: potentially contamination with the bacteria Burkholderia cepacia
Microbial Contamination of Non-Sterile Products
Microbial Contamination of Non-Sterile Products
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
CGMP Deviations: Recall initiated as a precautionary measure due to a potential risk of product contamination with the bacteria B. cepacia.
GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump.
GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump.
GMP Deviations; potential bacterial contamination may have been introduced to products through a contaminated diaphragm pump
Microbial contamination of Non-sterile Products; potential B. cepacia contamination
Microbial contamination of Non-sterile Products; potential B. cepacia contamination
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Microbial Contamination of Non Sterile Product; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Microbial contamination of Non-sterile Products; presence of yeast and potential B. cepacia contamination
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.